{"cursor":"3766","size":15,"audio":[],"currentlang":"en","article":"\n{{Infobox company| company_name = Neurocrine Biosciences| company_type = Public\n| company_logo = | foundation = 1992 |Joseph A. Mollica, Chairman Gary A. Lyons,\nCEO/President Paul W. Hawran, CFO/Exec. VP| location = San Diego, California,\nU.S. | key_people = Joseph A. Mollica, Chairman Gary A. Lyons,\nCEO/President | num_employees = 65 (2010) | industry = Biotechnology| homepage =\n[http://www.neurocrine.com/ www.neurocrine.com] | }}\n\n'Neurocrine Biosciences' is a biopharmaceutical company founded in 1992 and\nlocated in San Diego, California. The company tooks its name from the original\nfocus on therapies for neurological and endocrine diseases and disorders.\n\nThe company endured a significant setback on May 16, 2006 when the Food and Drug\nAdministration (FDA) denied approval for the 15-milligram dose of Indiplon, a\nmedication to treat insomnia. Neurocrine had developed the drug and was seeking\nto market it with partner, Pfizer. Announcement of the setback led to a 62% drop\nin stock price. Subsequent disclosures related to attempts to overcome this\nmajor setback caused a further drop in the stock by 30% in November 2006.\n\nLacking approval for Indiplon, the company laid off a 200-member sales force in\nJuly, 2006 and 100 employees across all areas of the company on August 7, 2006.\nIt announced a further cut of half the remaining workforce in December 2007, and\na fourth quarter loss of $128 million, including a $94 million write-\noff.\n\nBut recently the company has recovered the long term hope for recovery. All\nstarted on the 25th of May, 2010 when the shares jumped nearly 25% after the\ncompany announced its drug to treat endometriosis had achieved its main and\nsecondary goals in a study. The drug, called elagolix, reportedly showed\nstatistically significant reductions in dysmenorrhea, or pelvic pain during\nmenstruation as well as painful intercourse. And the shares of the company were\nup 69 cents to $3.40 on May the 25th trading, hitting a 52-week high of $4.23\nearly in the trading session.\n\nBut since that the stock has climbed from $4.23 to $6.16 at 25 June 2010. And\nthe expectatives for NBIX has raised about the elagolix trial success and of the\nsign for development deal with Boehringer. and Abbott\nLaboratories.\n","linknr":128,"url":"Neurocrine_Biosciences","recorded":1376418702,"links":["/w/index.php?title=Neurocrine_Biosciences&action=edit","/w/index.php?title=Neurocrine_Biosciences&action=edit","//bits.wikimedia.org/favicon/wikipedia.ico","/w/opensearch_desc.php","//en.wikipedia.org/w/api.php?action=rsd","//creativecommons.org/licenses/by-sa/3.0/","/w/index.php?title=Special:RecentChanges&feed=atom","http://en.wikipedia.org/wiki/Neurocrine_Biosciences","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmw.PopUpMediaTransform%7Cskins.vector&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.visualEditor.viewPageTarget.noscript&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=startup&only=scripts&skin=vector&*","//bits.wikimedia.org/geoiplookup","//meta.wikimedia.org","#mw-navigation","#p-search","//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png","//en.wikipedia.org/w/index.php?title=Neurocrine_Biosciences&action=edit","/wiki/Help:Introduction_to_referencing/1","/wiki/Template:Citation_needed","/wiki/Wikipedia:Verifiability#Burden_of_evidence","/wiki/File:Neurocrine-logo.PNG","//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Neurocrine-logo.PNG/220px-Neurocrine-logo.PNG","/wiki/Types_of_business_entity","/wiki/Public_company","/wiki/NASDAQ","http://www.nasdaq.com/symbol/nbix","/wiki/Biotechnology","/wiki/San_Diego,_California","/wiki/California","/wiki/United_States","/w/index.php?title=Joseph_A._Mollica&action=edit&redlink=1","/w/index.php?title=Gary_A._Lyons&action=edit&redlink=1","http://www.neurocrine.com/","/wiki/San_Diego","/wiki/California","/wiki/Neurological","/wiki/Endocrine","/wiki/Disease","/wiki/Food_and_Drug_Administration","/wiki/Indiplon","/wiki/Pfizer","#cite_note-1","#cite_note-2","#cite_note-3","#cite_note-4","/w/index.php?title=Neurocrine_Biosciences&action=edit&section=1","/w/index.php?title=Neurocrine_Biosciences&veaction=edit&section=1","#cite_ref-1","http://money.cnn.com/news/newsfeeds/articles/apwire/449c555bdf80888e2d2b2b9228ea2c18.htm","/wiki/Associated_Press","#cite_ref-2","http://www.foxbusiness.com/story/markets/industries/health-care/neurocrine-biosciences-shares-soar-drug-trial/","/wiki/FOXBusiness","#cite_ref-3","http://biz.yahoo.com/ap/100617/us_neurocrine_biosciences_contract.html?.v=1","/wiki/Associated_Press","#cite_ref-4","http://us.rd.yahoo.com/finance/external/forbes/SIG=139b4dhp7/*http%3A//www.forbes.com/2010/06/16/abbott-neurocrine-partner-on-endometriosis-drug-marketnewsvideo.html?partner=yahootix","/wiki/Forbes.com","/wiki/File:Factory.svg","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/Factory.svg/32px-Factory.svg.png","/wiki/Wikipedia:Stub","//en.wikipedia.org/w/index.php?title=Neurocrine_Biosciences&action=edit","/wiki/Template:Med-company-stub","/wiki/Template_talk:Med-company-stub","//en.wikipedia.org/w/index.php?title=Template:Med-company-stub&action=edit","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","http://en.wikipedia.org/w/index.php?title=Neurocrine_Biosciences&oldid=535362050","/wiki/Help:Category","/wiki/Category:Companies_in_the_NASDAQ_Biotechnology_Index","/wiki/Category:Biotechnology_companies_of_the_United_States","/wiki/Category:Companies_based_in_San_Diego,_California","/wiki/Category:Companies_established_in_1992","/wiki/Category:Medical_company_stubs","/wiki/Category:Articles_needing_additional_references_from_February_2008","/wiki/Category:All_articles_needing_additional_references","/w/index.php?title=Special:UserLogin&returnto=Neurocrine+Biosciences&type=signup","/w/index.php?title=Special:UserLogin&returnto=Neurocrine+Biosciences","/wiki/Neurocrine_Biosciences","/wiki/Talk:Neurocrine_Biosciences","#","/wiki/Neurocrine_Biosciences","/w/index.php?title=Neurocrine_Biosciences&action=edit","/w/index.php?title=Neurocrine_Biosciences&veaction=edit","/w/index.php?title=Neurocrine_Biosciences&action=history","#","/w/index.php","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","/wiki/Main_Page","/wiki/Main_Page","/wiki/Portal:Contents","/wiki/Portal:Featured_content","/wiki/Portal:Current_events","/wiki/Special:Random","https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en","/wiki/Help:Contents","/wiki/Wikipedia:About","/wiki/Wikipedia:Community_portal","/wiki/Special:RecentChanges","//en.wikipedia.org/wiki/Wikipedia:Contact_us","/wiki/Special:WhatLinksHere/Neurocrine_Biosciences","/wiki/Special:RecentChangesLinked/Neurocrine_Biosciences","/wiki/Wikipedia:File_Upload_Wizard","/wiki/Special:SpecialPages","/w/index.php?title=Neurocrine_Biosciences&oldid=535362050","/w/index.php?title=Neurocrine_Biosciences&action=info","//www.wikidata.org/wiki/Q7002174","/w/index.php?title=Special:Cite&page=Neurocrine_Biosciences&id=535362050","/w/index.php?title=Special:Book&bookcmd=book_creator&referer=Neurocrine+Biosciences","/w/index.php?title=Special:Book&bookcmd=render_article&arttitle=Neurocrine+Biosciences&oldid=535362050&writer=rl","/w/index.php?title=Neurocrine_Biosciences&printable=yes","#","//www.wikidata.org/wiki/Q7002174#sitelinks-wikipedia","//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License","//creativecommons.org/licenses/by-sa/3.0/","//wikimediafoundation.org/wiki/Terms_of_Use","//wikimediafoundation.org/wiki/Privacy_policy","//www.wikimediafoundation.org/","//wikimediafoundation.org/wiki/Privacy_policy","/wiki/Wikipedia:About","/wiki/Wikipedia:General_disclaimer","//en.wikipedia.org/wiki/Wikipedia:Contact_us","//en.m.wikipedia.org/wiki/Neurocrine_Biosciences","//wikimediafoundation.org/","//bits.wikimedia.org/images/wikimedia-button.png","//www.mediawiki.org/","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=scripts&skin=vector&*"],"instances":[],"pdf":[],"categories":["Companies in the NASDAQ Biotechnology Index","Biotechnology companies of the United States","Companies based in San Diego, California","Companies established in 1992"],"headings":["References"],"image":["//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Neurocrine-logo.PNG/220px-Neurocrine-logo.PNG","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/Factory.svg/32px-Factory.svg.png","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[],"members":[],"related":["Public_company","San_Diego,_California","California","United_States","Joseph_A._Mollica","Gary_A._Lyons","Biotechnology","San_Diego","California","Neurological","Endocrine","Disease","Food_and_Drug_Administration","Indiplon","Pfizer"]}